Jessica’s presentation focused on the main reasons patients drop out of clinical trials, and the steps we can take to reduce the burden on patients and increase study retention rates.

Listening to the patient voice is more important than ever. As the decentralisation of clinical trials becomes the norm, more patients are actively involved in the trial design process.

To show our colours for Rare Disease Day 2021 and to gain greater insight into the patient experience, we facilitated a team Lunch and Learn with Rachael Mole, founder of Sick in the City – an organisation that supports people living with chronic and invisible illnesses and disabilities.

The need for patients and their families to travel to and from clinical study sites, particularly those who live in remote places, has been a huge obstacle over the past 12 months. Some of these families require long-term stays in countries far from their own.

Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.

Our CEO Tarquin Scadding-Hunt has more than 20 years’ experience in the pharma industry and has overseen many exciting developments in the business.

Passionate about making sure we do everything with compassion and kindness – inside and outside the business – Tarquin shares with us his vision for the company, what makes us different, and how he’s supporting us to create remarkable patient experiences.